6 research outputs found
Image_3_Global Burden of cardiomyopathy and myocarditis in the older adults from 1990 to 2019.TIF
BackgroundCardiomyopathy and myocarditis (CM-MC) are common chronic diseases causing heart failure in older adults. We aimed to analyze the burden of CM-MC in older adults aged 60β89 years at the global, regional, and national levels in 204 countries from 1990 to 2019.MethodsDetailed data on CM-MC from 1990 to 2019 were analyzed from the Global Burden of Diseases Study 2019, including incidence, mortality, disability-adjusted life years (DALYs) and the proportion of deaths caused by different risks factors. All results are presented as numbers, age-standardized rates per 100,000 person-years and estimated annual percentage change (EAPC) with an uncertainty interval of 95%.ResultsGlobally, there were 475,458 (339,942β638,363) incidence cases from CM-MC in 2019; with an age-standardized incidence rate (ASIR) of 16 (13β19.3) per 100,000 person-years. And there were 185,308 (154,610β200,448) deaths, with the age-standardized mortality rate (ASMR) being 4.4 (3.7β4.8). CM-MC resulted in 3,372,716 (2,931,247β3,693,622) DALYs, with an age-standardized DALYs rate (ASDR) of 114.8 (98.7β126.1). Estimated annual percentage change (EAPCs) for ARIS, ARMS, and ARDS has decreased. At the national level, the United States of America had the highest mortality [21,372 (18,924β24,241)] and disability-adjusted life years [407,712 (370,234β470,165)]. And China had the highest number of incident cases [122, 266 (85,925β166,095)]. Globally, high systolic blood pressure and alcohol consumption were the top two risk factors for the proportion of CM-MC deaths.ConclusionCM-MC is still an important cause of early death and chronic disability in older adults. Based on this study, public health agencies should seek more effective methods to prevent and treat CM-MC.</p
Image_5_Global Burden of cardiomyopathy and myocarditis in the older adults from 1990 to 2019.TIF
BackgroundCardiomyopathy and myocarditis (CM-MC) are common chronic diseases causing heart failure in older adults. We aimed to analyze the burden of CM-MC in older adults aged 60β89 years at the global, regional, and national levels in 204 countries from 1990 to 2019.MethodsDetailed data on CM-MC from 1990 to 2019 were analyzed from the Global Burden of Diseases Study 2019, including incidence, mortality, disability-adjusted life years (DALYs) and the proportion of deaths caused by different risks factors. All results are presented as numbers, age-standardized rates per 100,000 person-years and estimated annual percentage change (EAPC) with an uncertainty interval of 95%.ResultsGlobally, there were 475,458 (339,942β638,363) incidence cases from CM-MC in 2019; with an age-standardized incidence rate (ASIR) of 16 (13β19.3) per 100,000 person-years. And there were 185,308 (154,610β200,448) deaths, with the age-standardized mortality rate (ASMR) being 4.4 (3.7β4.8). CM-MC resulted in 3,372,716 (2,931,247β3,693,622) DALYs, with an age-standardized DALYs rate (ASDR) of 114.8 (98.7β126.1). Estimated annual percentage change (EAPCs) for ARIS, ARMS, and ARDS has decreased. At the national level, the United States of America had the highest mortality [21,372 (18,924β24,241)] and disability-adjusted life years [407,712 (370,234β470,165)]. And China had the highest number of incident cases [122, 266 (85,925β166,095)]. Globally, high systolic blood pressure and alcohol consumption were the top two risk factors for the proportion of CM-MC deaths.ConclusionCM-MC is still an important cause of early death and chronic disability in older adults. Based on this study, public health agencies should seek more effective methods to prevent and treat CM-MC.</p
Image_1_Global Burden of cardiomyopathy and myocarditis in the older adults from 1990 to 2019.TIF
BackgroundCardiomyopathy and myocarditis (CM-MC) are common chronic diseases causing heart failure in older adults. We aimed to analyze the burden of CM-MC in older adults aged 60β89 years at the global, regional, and national levels in 204 countries from 1990 to 2019.MethodsDetailed data on CM-MC from 1990 to 2019 were analyzed from the Global Burden of Diseases Study 2019, including incidence, mortality, disability-adjusted life years (DALYs) and the proportion of deaths caused by different risks factors. All results are presented as numbers, age-standardized rates per 100,000 person-years and estimated annual percentage change (EAPC) with an uncertainty interval of 95%.ResultsGlobally, there were 475,458 (339,942β638,363) incidence cases from CM-MC in 2019; with an age-standardized incidence rate (ASIR) of 16 (13β19.3) per 100,000 person-years. And there were 185,308 (154,610β200,448) deaths, with the age-standardized mortality rate (ASMR) being 4.4 (3.7β4.8). CM-MC resulted in 3,372,716 (2,931,247β3,693,622) DALYs, with an age-standardized DALYs rate (ASDR) of 114.8 (98.7β126.1). Estimated annual percentage change (EAPCs) for ARIS, ARMS, and ARDS has decreased. At the national level, the United States of America had the highest mortality [21,372 (18,924β24,241)] and disability-adjusted life years [407,712 (370,234β470,165)]. And China had the highest number of incident cases [122, 266 (85,925β166,095)]. Globally, high systolic blood pressure and alcohol consumption were the top two risk factors for the proportion of CM-MC deaths.ConclusionCM-MC is still an important cause of early death and chronic disability in older adults. Based on this study, public health agencies should seek more effective methods to prevent and treat CM-MC.</p
Table_1_Global Burden of cardiomyopathy and myocarditis in the older adults from 1990 to 2019.docx
BackgroundCardiomyopathy and myocarditis (CM-MC) are common chronic diseases causing heart failure in older adults. We aimed to analyze the burden of CM-MC in older adults aged 60β89 years at the global, regional, and national levels in 204 countries from 1990 to 2019.MethodsDetailed data on CM-MC from 1990 to 2019 were analyzed from the Global Burden of Diseases Study 2019, including incidence, mortality, disability-adjusted life years (DALYs) and the proportion of deaths caused by different risks factors. All results are presented as numbers, age-standardized rates per 100,000 person-years and estimated annual percentage change (EAPC) with an uncertainty interval of 95%.ResultsGlobally, there were 475,458 (339,942β638,363) incidence cases from CM-MC in 2019; with an age-standardized incidence rate (ASIR) of 16 (13β19.3) per 100,000 person-years. And there were 185,308 (154,610β200,448) deaths, with the age-standardized mortality rate (ASMR) being 4.4 (3.7β4.8). CM-MC resulted in 3,372,716 (2,931,247β3,693,622) DALYs, with an age-standardized DALYs rate (ASDR) of 114.8 (98.7β126.1). Estimated annual percentage change (EAPCs) for ARIS, ARMS, and ARDS has decreased. At the national level, the United States of America had the highest mortality [21,372 (18,924β24,241)] and disability-adjusted life years [407,712 (370,234β470,165)]. And China had the highest number of incident cases [122, 266 (85,925β166,095)]. Globally, high systolic blood pressure and alcohol consumption were the top two risk factors for the proportion of CM-MC deaths.ConclusionCM-MC is still an important cause of early death and chronic disability in older adults. Based on this study, public health agencies should seek more effective methods to prevent and treat CM-MC.</p
Image_2_Global Burden of cardiomyopathy and myocarditis in the older adults from 1990 to 2019.TIF
BackgroundCardiomyopathy and myocarditis (CM-MC) are common chronic diseases causing heart failure in older adults. We aimed to analyze the burden of CM-MC in older adults aged 60β89 years at the global, regional, and national levels in 204 countries from 1990 to 2019.MethodsDetailed data on CM-MC from 1990 to 2019 were analyzed from the Global Burden of Diseases Study 2019, including incidence, mortality, disability-adjusted life years (DALYs) and the proportion of deaths caused by different risks factors. All results are presented as numbers, age-standardized rates per 100,000 person-years and estimated annual percentage change (EAPC) with an uncertainty interval of 95%.ResultsGlobally, there were 475,458 (339,942β638,363) incidence cases from CM-MC in 2019; with an age-standardized incidence rate (ASIR) of 16 (13β19.3) per 100,000 person-years. And there were 185,308 (154,610β200,448) deaths, with the age-standardized mortality rate (ASMR) being 4.4 (3.7β4.8). CM-MC resulted in 3,372,716 (2,931,247β3,693,622) DALYs, with an age-standardized DALYs rate (ASDR) of 114.8 (98.7β126.1). Estimated annual percentage change (EAPCs) for ARIS, ARMS, and ARDS has decreased. At the national level, the United States of America had the highest mortality [21,372 (18,924β24,241)] and disability-adjusted life years [407,712 (370,234β470,165)]. And China had the highest number of incident cases [122, 266 (85,925β166,095)]. Globally, high systolic blood pressure and alcohol consumption were the top two risk factors for the proportion of CM-MC deaths.ConclusionCM-MC is still an important cause of early death and chronic disability in older adults. Based on this study, public health agencies should seek more effective methods to prevent and treat CM-MC.</p
Image_4_Global Burden of cardiomyopathy and myocarditis in the older adults from 1990 to 2019.TIF
BackgroundCardiomyopathy and myocarditis (CM-MC) are common chronic diseases causing heart failure in older adults. We aimed to analyze the burden of CM-MC in older adults aged 60β89 years at the global, regional, and national levels in 204 countries from 1990 to 2019.MethodsDetailed data on CM-MC from 1990 to 2019 were analyzed from the Global Burden of Diseases Study 2019, including incidence, mortality, disability-adjusted life years (DALYs) and the proportion of deaths caused by different risks factors. All results are presented as numbers, age-standardized rates per 100,000 person-years and estimated annual percentage change (EAPC) with an uncertainty interval of 95%.ResultsGlobally, there were 475,458 (339,942β638,363) incidence cases from CM-MC in 2019; with an age-standardized incidence rate (ASIR) of 16 (13β19.3) per 100,000 person-years. And there were 185,308 (154,610β200,448) deaths, with the age-standardized mortality rate (ASMR) being 4.4 (3.7β4.8). CM-MC resulted in 3,372,716 (2,931,247β3,693,622) DALYs, with an age-standardized DALYs rate (ASDR) of 114.8 (98.7β126.1). Estimated annual percentage change (EAPCs) for ARIS, ARMS, and ARDS has decreased. At the national level, the United States of America had the highest mortality [21,372 (18,924β24,241)] and disability-adjusted life years [407,712 (370,234β470,165)]. And China had the highest number of incident cases [122, 266 (85,925β166,095)]. Globally, high systolic blood pressure and alcohol consumption were the top two risk factors for the proportion of CM-MC deaths.ConclusionCM-MC is still an important cause of early death and chronic disability in older adults. Based on this study, public health agencies should seek more effective methods to prevent and treat CM-MC.</p